{"id":"palliative-chemotherapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (anemia, neutropenia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Diarrhea or constipation"}]},"_chembl":{"chemblId":"CHEMBL4297950","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Palliative chemotherapy uses conventional cytotoxic agents to target rapidly dividing cancer cells, thereby reducing tumor burden and associated symptoms such as pain, obstruction, or bleeding. Unlike curative chemotherapy regimens, palliative approaches prioritize quality of life and symptom management over aggressive dose intensification, often using lower doses or less frequent schedules to balance efficacy with tolerability.","oneSentence":"Palliative chemotherapy works by administering cytotoxic drugs to slow cancer growth and alleviate symptoms in patients with advanced or metastatic disease where cure is not the primary goal.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:50:51.534Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced or metastatic cancer (specific cancer type not specified in available information)"}]},"trialDetails":[{"nctId":"NCT07498972","phase":"NA","title":"Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer","status":"COMPLETED","sponsor":"Shanxi Province Cancer Hospital","startDate":"2023-01-01","conditions":"Advanced Lung Cancer, Cancer-related Fatigue","enrollment":100},{"nctId":"NCT04530565","phase":"PHASE3","title":"Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-25","conditions":"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":348},{"nctId":"NCT05001880","phase":"PHASE2","title":"Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-03-22","conditions":"Peritoneal Malignant Mesothelioma","enrollment":66},{"nctId":"NCT07495358","phase":"NA","title":"Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cancer Undergoing Chemotherapy","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2026-04-15","conditions":"Breast Neoplasms, Syndrome","enrollment":30},{"nctId":"NCT07152821","phase":"PHASE3","title":"Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2026-03-31","conditions":"Colorectal Cancer","enrollment":834},{"nctId":"NCT07487168","phase":"PHASE1","title":"Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-03","conditions":"Peritoneal Carcinomatosis","enrollment":24},{"nctId":"NCT07486089","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer, Triple-Negative Breast Cancer (TNBC)","enrollment":60},{"nctId":"NCT07015944","phase":"NA","title":"Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan","status":"RECRUITING","sponsor":"Pakistan Institute of Living and Learning","startDate":"2025-06-13","conditions":"Major Depressive Disorder (MDD), Breast Cancer Survivor","enrollment":26376},{"nctId":"NCT06412510","phase":"PHASE1, PHASE2","title":"Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-09-05","conditions":"Ovarian Cancer, Epithelial Ovarian Cancer, Pancreatic Adenocarcinoma","enrollment":22},{"nctId":"NCT07478185","phase":"NA","title":"Prehab for Pancreatic Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Worcester","startDate":"2026-02","conditions":"Pancreatic Cancer, Adult, Prehabilitation","enrollment":20},{"nctId":"NCT07474337","phase":"NA","title":"The Effect of Mindfulness-Based Breathing Exercises on Symptom Control","status":"RECRUITING","sponsor":"Firat University","startDate":"2026-03-10","conditions":"Breast Cancer","enrollment":72},{"nctId":"NCT07474090","phase":"NA","title":"Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-07-05","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":120},{"nctId":"NCT00420563","phase":"PHASE2","title":"Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2009-09-25","conditions":"Cancer","enrollment":88},{"nctId":"NCT05874297","phase":"NA","title":"Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-06-01","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":50},{"nctId":"NCT07467863","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC","enrollment":48},{"nctId":"NCT07350850","phase":"PHASE2","title":"A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort)","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-12-25","conditions":"PCNSL, Primary Central Nervous System Lymphoma","enrollment":110},{"nctId":"NCT06915116","phase":"PHASE2","title":"Acupuncture for People Experiencing Period Loss Due to Chemotherapy","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-03-31","conditions":"Cancer, Period Problem","enrollment":60},{"nctId":"NCT07191418","phase":"NA","title":"Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors","status":"NOT_YET_RECRUITING","sponsor":"Roberto Valente","startDate":"2026-03","conditions":"Pancreatic Cancer Metastatic to Liver","enrollment":178},{"nctId":"NCT04568278","phase":"NA","title":"Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment.","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2020-10-05","conditions":"Neoplasms","enrollment":222},{"nctId":"NCT07192770","phase":"","title":"G-CSF-Induced Bone Pain and Supportive Care Approaches","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2025-09-27","conditions":"Solid Tumors, Chemotherapy-induced Neutropenia","enrollment":225},{"nctId":"NCT07423169","phase":"NA","title":"Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer","status":"RECRUITING","sponsor":"Karl Landsteiner University of Health Sciences","startDate":"2026-02-02","conditions":"Lung Adenocarcinoma, Bulky Tumors, Unresectable Cancer","enrollment":10},{"nctId":"NCT05403723","phase":"PHASE1","title":"Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC","status":"SUSPENDED","sponsor":"University of Maryland, Baltimore","startDate":"2026-06-30","conditions":"Extensive-stage Small-cell Lung Cancer","enrollment":50},{"nctId":"NCT07411144","phase":"PHASE2","title":"Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2020-03-15","conditions":"Diffuse Pleural Mesothelioma (DPM)","enrollment":64},{"nctId":"NCT06340906","phase":"NA","title":"Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-09-01","conditions":"Cancer","enrollment":20},{"nctId":"NCT06615830","phase":"","title":"Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Prof. Dr. med. Dres. h.c. Jan Schmidt, MME","startDate":"2026-06-01","conditions":"Pancreas Neoplasms, Pancreatic Neoplasms, Pancreatic Cancer Metastatic","enrollment":185},{"nctId":"NCT04384146","phase":"PHASE1","title":"Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-05-07","conditions":"Non-Small Cell Lung Cancer","enrollment":41},{"nctId":"NCT05408507","phase":"NA","title":"Care Planning Framework in Advanced Cancer (ABC123)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-02-15","conditions":"Advanced Cancer","enrollment":70},{"nctId":"NCT00183625","phase":"PHASE4","title":"Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2000-06","conditions":"Schizophrenia","enrollment":107},{"nctId":"NCT07290972","phase":"","title":"Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India","status":"RECRUITING","sponsor":"Tata Memorial Hospital","startDate":"2021-02-01","conditions":"Cervical Cancer Screening, Gynecologic Cancers, Treatment Compliance","enrollment":618},{"nctId":"NCT07218874","phase":"NA","title":"Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-02-02","conditions":"Cancer, Solid Tumor Cancer, Chemotherapy","enrollment":50},{"nctId":"NCT06804135","phase":"","title":"Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer","status":"RECRUITING","sponsor":"Tata Memorial Hospital","startDate":"2025-10-25","conditions":"Cervical Carcinoma","enrollment":110},{"nctId":"NCT06978127","phase":"NA","title":"Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-08-28","conditions":"Chronic Kidney Disease Requiring Hemodialysis","enrollment":424},{"nctId":"NCT07372326","phase":"NA","title":"A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2025-05-15","conditions":"Stroke Patients With Constipation","enrollment":105},{"nctId":"NCT07175376","phase":"NA","title":"Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-05","conditions":"Cancer, Frail, Chemotherapy","enrollment":32},{"nctId":"NCT07362615","phase":"NA","title":"An AI-Assisted Art Therapy Co-Creation Intervention","status":"NOT_YET_RECRUITING","sponsor":"Gazi University","startDate":"2026-01-20","conditions":"Pediatric Cancer Chemotherapy-Related Symptoms Anxiety","enrollment":60},{"nctId":"NCT04586530","phase":"NA","title":"Telehealth and Memory Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2021-03-18","conditions":"Chemotherapy-related Cognitive Dysfunction","enrollment":220},{"nctId":"NCT02813135","phase":"PHASE1, PHASE2","title":"European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2016-08-03","conditions":"Pediatric Cancer","enrollment":472},{"nctId":"NCT05649852","phase":"NA","title":"Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy","status":"RECRUITING","sponsor":"GCS Ramsay Santé pour l'Enseignement et la Recherche","startDate":"2023-03-23","conditions":"Chemotherapy Effect","enrollment":192},{"nctId":"NCT07345221","phase":"NA","title":"Effect of Hilotherapy in the Management of Symptoms Related to Taxane-Associated Peripheral Neuropathy","status":"RECRUITING","sponsor":"Nuran Ayşen Pamir Aksoy","startDate":"2025-06-04","conditions":"Peripheric Neuropathy","enrollment":60},{"nctId":"NCT07335770","phase":"","title":"Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)","status":"ENROLLING_BY_INVITATION","sponsor":"Minjie Lu","startDate":"2008-01-01","conditions":"Cardiac Masses","enrollment":2000},{"nctId":"NCT07325851","phase":"","title":"Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.","status":"NOT_YET_RECRUITING","sponsor":"Bernardino Clavo, MD, PhD","startDate":"2026-01-14","conditions":"Chemotherapy-Induced Peripheral Neuropathy, Radiation Toxicity, Chronic Pain","enrollment":120},{"nctId":"NCT07327138","phase":"NA","title":"Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.","status":"RECRUITING","sponsor":"Bahaa Bou Dargham","startDate":"2025-10-15","conditions":"Acute Lymphoblastic Leukemia ALL","enrollment":60},{"nctId":"NCT04049669","phase":"PHASE2","title":"Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG","status":"ACTIVE_NOT_RECRUITING","sponsor":"Theodore S. Johnson","startDate":"2019-10-02","conditions":"Glioblastoma, Medulloblastoma, Ependymoma","enrollment":130},{"nctId":"NCT06680622","phase":"PHASE2","title":"Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2025-03-03","conditions":"Metastatic Gastro-esophageal Adenocarcinoma","enrollment":126},{"nctId":"NCT05717166","phase":"PHASE3","title":"A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.","status":"RECRUITING","sponsor":"David Palma","startDate":"2023-10-06","conditions":"Metastatic Tumor","enrollment":180},{"nctId":"NCT06141785","phase":"NA","title":"Early Nutritional Intervention in Patients With Cancer","status":"RECRUITING","sponsor":"Gødstrup Hospital","startDate":"2024-06-01","conditions":"Nutritional Intervention, Cancer, Malnutrition","enrollment":200},{"nctId":"NCT03042169","phase":"PHASE3","title":"Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2021-08-25","conditions":"Gastric Adenocarcinoma","enrollment":6},{"nctId":"NCT07290491","phase":"PHASE3","title":"Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-06-19","conditions":"Cancer","enrollment":854},{"nctId":"NCT02297217","phase":"PHASE2","title":"Chemoradiotherapy for Advanced Esophageal Cancer","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2019-11-21","conditions":"Esophageal Cancer","enrollment":50},{"nctId":"NCT07198581","phase":"NA","title":"AI-Assisted Chemotherapy Side Effect Management","status":"RECRUITING","sponsor":"Incheon St.Mary's Hospital","startDate":"2025-11-12","conditions":"Breast Cancer, Colorectal Cancer","enrollment":174},{"nctId":"NCT07200791","phase":"NA","title":"The Effect of Mobile Application-Assisted Nursing Services on Symptom Control in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Fenerbahce University","startDate":"2025-12","conditions":"Symptom Management, Quality of Life","enrollment":74},{"nctId":"NCT07263178","phase":"","title":"A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.","status":"RECRUITING","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2025-11-07","conditions":"Metastatic Colorectal Cancer","enrollment":1000},{"nctId":"NCT05440916","phase":"PHASE2","title":"Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer","status":"COMPLETED","sponsor":"University Medical Centre Maribor","startDate":"2022-07-14","conditions":"Carcinoma, Non-Small-Cell Lung, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer","enrollment":50},{"nctId":"NCT07258043","phase":"","title":"Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Hospital General de Mexico","startDate":"2025-07-23","conditions":"Acute Lymphobkastic Leukemia, Leukemia, Overall Survival","enrollment":45},{"nctId":"NCT05723107","phase":"PHASE1","title":"EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-03-31","conditions":"Pancreatic Cancer","enrollment":15},{"nctId":"NCT03862911","phase":"NA","title":"Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"British Columbia Cancer Agency","startDate":"2019-11-01","conditions":"Metastatic Tumors","enrollment":330},{"nctId":"NCT04942717","phase":"NA","title":"Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-06-18","conditions":"Solid Tumor, Solid Tumor, Adult, Solid Tumor, Unspecified, Adult","enrollment":234},{"nctId":"NCT07235241","phase":"NA","title":"The Effect of Digital Games on Ethical Sensitivity and Decision Making in Nursing Students","status":"NOT_YET_RECRUITING","sponsor":"Istanbul Medeniyet University","startDate":"2026-03","conditions":"Decision Making, Ethics","enrollment":60},{"nctId":"NCT04549428","phase":"PHASE2","title":"Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC","status":"TERMINATED","sponsor":"Oncology Institute of Southern Switzerland","startDate":"2020-10-01","conditions":"NSCLC Stage IV","enrollment":12},{"nctId":"NCT07225855","phase":"NA","title":"Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers","status":"NOT_YET_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-07-09","conditions":"Localized Head and Neck Carcinoma","enrollment":36},{"nctId":"NCT06978582","phase":"NA","title":"Effectiveness and Safety of a Tele-Rehabilitation Program on Fatigue and Related Variables in Chronic Fatigue Syndrome and Post COVID Syndrome","status":"RECRUITING","sponsor":"University of Seville","startDate":"2025-10-01","conditions":"Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME), Post COVID Syndrome","enrollment":147},{"nctId":"NCT05825287","phase":"NA","title":"The Effect of Patient Education Given by Teach-Back Method on Managing Chemotherapy Symptoms","status":"COMPLETED","sponsor":"Marmara University","startDate":"2021-01-01","conditions":"Teach-Back Communication","enrollment":80},{"nctId":"NCT04883671","phase":"NA","title":"Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-12-27","conditions":"Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma","enrollment":32},{"nctId":"NCT03721341","phase":"PHASE3","title":"Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Palma","startDate":"2019-02-22","conditions":"Metastatic Tumors","enrollment":204},{"nctId":"NCT02246725","phase":"","title":"Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.","status":"COMPLETED","sponsor":"Lund University Hospital","startDate":"2014-10","conditions":"Tumor in Upper Gastrointestinal Canal or Patients With Colorectal Cancer","enrollment":108},{"nctId":"NCT04789980","phase":"","title":"Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2021-01-29","conditions":"Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer","enrollment":799},{"nctId":"NCT07164690","phase":"PHASE2","title":"Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-09","conditions":"Esophageal Adenocarcinoma, Radiotherapy","enrollment":32},{"nctId":"NCT03022032","phase":"NA","title":"The HOPE Trial and the SMART Study","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-04-12","conditions":"Gynecologic Cancer","enrollment":102},{"nctId":"NCT05417737","phase":"","title":"Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025","status":"RECRUITING","sponsor":"Bernardino Clavo, MD, PhD","startDate":"2022-06-15","conditions":"Radiation Toxicity, Chemotherapeutic Toxicity, Chemotherapy-induced Peripheral Neuropathy","enrollment":105},{"nctId":"NCT05449366","phase":"PHASE1, PHASE2","title":"Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2022-02-01","conditions":"Peritoneal Malignant Mesothelioma","enrollment":7},{"nctId":"NCT02330926","phase":"PHASE3","title":"Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2015-04","conditions":"Cachexia, Neoplasms","enrollment":221},{"nctId":"NCT03724994","phase":"","title":"Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer","status":"COMPLETED","sponsor":"Lund University","startDate":"2018-10-30","conditions":"Periampullary Adenocarcinoma, Periampullary Cancer, Pancreatic Cancer","enrollment":201},{"nctId":"NCT01351584","phase":"","title":"Tumour Registry Breast Cancer","status":"COMPLETED","sponsor":"iOMEDICO AG","startDate":"2007-02","conditions":"Breast Cancer","enrollment":4500},{"nctId":"NCT00910819","phase":"","title":"Tumour Registry Colorectal Cancer","status":"COMPLETED","sponsor":"iOMEDICO AG","startDate":"2006-09","conditions":"Colorectal Cancer","enrollment":7000},{"nctId":"NCT06529081","phase":"NA","title":"Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer","status":"RECRUITING","sponsor":"Copernicus Memorial Hospital","startDate":"2024-04-01","conditions":"Small Cell Lung Carcinoma","enrollment":165},{"nctId":"NCT07144449","phase":"NA","title":"Nurse-Led Electronic Patient-Reported Outcome System to Improve Quality of Life in Chemotherapy Patients","status":"COMPLETED","sponsor":"CHIAO-CHI KUAN","startDate":"2024-05-04","conditions":"Neoplasms, Nursing Caries","enrollment":120},{"nctId":"NCT06764680","phase":"PHASE2","title":"Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-12-31","conditions":"Colorectal Cancer Metastatic, Chemotherapy, Targeted Therapy","enrollment":57},{"nctId":"NCT06904079","phase":"NA","title":"Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2024-03-12","conditions":"Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder","enrollment":82},{"nctId":"NCT04822766","phase":"NA","title":"A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-12-31","conditions":"Acute Myeloid Leukemia","enrollment":24},{"nctId":"NCT05038254","phase":"NA","title":"Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-05-12","conditions":"Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8","enrollment":750},{"nctId":"NCT04952922","phase":"","title":"Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2021-10-27","conditions":"Recurrent Oropharynx Carcinoma","enrollment":25},{"nctId":"NCT06290505","phase":"PHASE2","title":"A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study","status":"RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2021-12-08","conditions":"Esophageal Cancer","enrollment":54},{"nctId":"NCT01781728","phase":"PHASE2","title":"Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2013-01-01","conditions":"Pancreatic Cancer, Periampullary Adenocarcinoma","enrollment":48},{"nctId":"NCT03348150","phase":"PHASE3","title":"Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-10-01","conditions":"Stomach Neoplasm, Peritoneal Carcinomatosis","enrollment":102},{"nctId":"NCT04669301","phase":"NA","title":"Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2021-04-02","conditions":"Cancer-related Problem/Condition, Cognitive Impairment","enrollment":72},{"nctId":"NCT00354393","phase":"PHASE2","title":"Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2002-08","conditions":"Malignant Mesothelioma","enrollment":9},{"nctId":"NCT05582772","phase":"NA","title":"TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-05-23","conditions":"Metastatic Prostate Cancer","enrollment":168},{"nctId":"NCT03764553","phase":"PHASE2","title":"Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2019-05-01","conditions":"Esophageal Cancer","enrollment":320},{"nctId":"NCT07032103","phase":"","title":"Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2022-06-01","conditions":"Lymphoma","enrollment":2000},{"nctId":"NCT06167785","phase":"PHASE2","title":"A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-06-04","conditions":"Large B-cell Lymphoma","enrollment":76},{"nctId":"NCT06775678","phase":"PHASE2","title":"Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2024-10-01","conditions":"Lung Cancers, Radiation Treatment for Tumors","enrollment":84},{"nctId":"NCT05014399","phase":"","title":"Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy","status":"RECRUITING","sponsor":"Joseph McCollom","startDate":"2021-09-20","conditions":"Neoplasm, Colorectal, Cognitive Impairment, Cognitive Dysfunction","enrollment":60},{"nctId":"NCT06678048","phase":"PHASE2","title":"Arsenous Acid for Refractory Triple-Negative Breast Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-10-23","conditions":"Breast Cancer","enrollment":12},{"nctId":"NCT06208371","phase":"PHASE3","title":"Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-01-15","conditions":"Colorectal Neoplasms Malignant","enrollment":117},{"nctId":"NCT05704985","phase":"PHASE1","title":"Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"DEKA Biosciences","startDate":"2023-04-03","conditions":"Cancer, Solid Tumor, Colorectal Cancer","enrollment":39},{"nctId":"NCT05650827","phase":"NA","title":"Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2023-02-24","conditions":"Gastro-esophageal Cancer","enrollment":54},{"nctId":"NCT01792934","phase":"NA","title":"Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2013-05","conditions":"Multi-organ Metastatic Colorectal Cancer","enrollment":478},{"nctId":"NCT06914557","phase":"PHASE2","title":"Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2025-03-03","conditions":"CIPN - Chemotherapy-Induced Peripheral Neuropathy, Pain","enrollment":50},{"nctId":"NCT06183164","phase":"NA","title":"Awareness Based Stress Reduction Program Applied to Breast Cancer Patients Receiving Chemotherapy","status":"COMPLETED","sponsor":"Firat University","startDate":"2023-10-29","conditions":"Breast Cancer Patients Receiving Chemotherapy","enrollment":60},{"nctId":"NCT04185428","phase":"NA","title":"Investigating Integrative Therapies for Symptom Management in Adults With Acute Leukemia","status":"TERMINATED","sponsor":"University of Florida","startDate":"2023-08-09","conditions":"Acute Myeloid Leukemia","enrollment":9}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"ASPARTATE AMINOTRANSFERASE INCREASED"},{"count":1,"reaction":"DISEASE PROGRESSION"},{"count":1,"reaction":"FEBRILE NEUTROPENIA"},{"count":1,"reaction":"IMMUNOSUPPRESSION"},{"count":1,"reaction":"LEUKOPENIA"},{"count":1,"reaction":"LYMPHOPENIA"},{"count":1,"reaction":"NEUTROPENIA"},{"count":1,"reaction":"PERTUSSIS"},{"count":1,"reaction":"PNEUMOCYSTIS JIROVECI PNEUMONIA"}],"_approvalHistory":[],"publicationCount":3659,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Palliative Chemotherapy","genericName":"Palliative Chemotherapy","companyName":"Sun Yat-sen University","companyId":"sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Palliative chemotherapy works by administering cytotoxic drugs to slow cancer growth and alleviate symptoms in patients with advanced or metastatic disease where cure is not the primary goal. Used for Advanced or metastatic cancer (specific cancer type not specified in available information).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}